The Next Wave of Devices are Liquids: Microfluidics

Over the course of history, our interest in the fundamentals of biology, especially proteomics — the study of all the proteins in the human body — has been completely reliant on expensive testing. Despite this, we’ve been able to make considerable advances in the fields of drug development to cellular microbiology.

As our development of biological products become increasingly prolific, we’re seeing that our previous environmental and in-vivo testing mechanisms are much too expensive and impractical, and even oftentimes inaccurate.